A. M. Amin

456 total citations
39 papers, 376 citations indexed

About

A. M. Amin is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmacology and Molecular Biology. According to data from OpenAlex, A. M. Amin has authored 39 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in A. M. Amin's work include Radiopharmaceutical Chemistry and Applications (26 papers), Medical Imaging Techniques and Applications (13 papers) and Nanoparticle-Based Drug Delivery (6 papers). A. M. Amin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (26 papers), Medical Imaging Techniques and Applications (13 papers) and Nanoparticle-Based Drug Delivery (6 papers). A. M. Amin collaborates with scholars based in Egypt, China and Poland. A. M. Amin's co-authors include M. H. Sanad, Talib Al-Mishlab, J. P. M. Ellul, Magdy A. Amin, Ismail Ibrahim, Abdulaziz Mohsen Al-mahallawi, Ahmed Abdelbary, Wael Mamdouh, Ahmed Abd El-Bary and Nasser S. M. Ismail and has published in prestigious journals such as European Heart Journal, International Journal of Pharmaceutics and European Journal of Pharmaceutical Sciences.

In The Last Decade

A. M. Amin

36 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Amin Egypt 11 194 88 65 62 46 39 376
Adli A. Selim Egypt 13 110 0.6× 21 0.2× 53 0.8× 77 1.2× 44 1.0× 29 379
Emilija Janevik-Ivanovska North Macedonia 7 141 0.7× 17 0.2× 39 0.6× 51 0.8× 43 0.9× 23 350
Makbule Aşıkoğlu Türkiye 11 114 0.6× 52 0.6× 60 0.9× 33 0.5× 73 1.6× 31 298
Mostafa Erfani Iran 13 239 1.2× 88 1.0× 74 1.1× 125 2.0× 107 2.3× 75 525
Silvana Mansueto Italy 5 52 0.3× 25 0.3× 14 0.2× 48 0.8× 8 0.2× 5 305
David Hoskovec Czechia 10 19 0.1× 50 0.6× 45 0.7× 61 1.0× 53 1.2× 35 268
Wojciech Latos Poland 15 43 0.2× 78 0.9× 358 5.5× 81 1.3× 47 1.0× 37 570
George Makris Greece 14 138 0.7× 294 3.3× 57 0.9× 88 1.4× 72 1.6× 27 825
Kübra Durkan Türkiye 11 124 0.6× 71 0.8× 81 1.2× 72 1.2× 66 1.4× 23 350
Hailing Tang China 12 28 0.1× 32 0.4× 118 1.8× 216 3.5× 109 2.4× 24 402

Countries citing papers authored by A. M. Amin

Since Specialization
Citations

This map shows the geographic impact of A. M. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Amin more than expected).

Fields of papers citing papers by A. M. Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Amin. The network helps show where A. M. Amin may publish in the future.

Co-authorship network of co-authors of A. M. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Amin. A scholar is included among the top collaborators of A. M. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Amin. A. M. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Yousry, Carol, et al.. (2023). Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology. 80. 104171–104171. 10 indexed citations
4.
Amin, A. M., et al.. (2022). A new modality in targeted delivery of epirubicin for tumor theranosis based on PEGylated silver nanoparticles: Design, radiolabeling and bioevaluation. International Journal of Pharmaceutics. 629. 122358–122358. 4 indexed citations
5.
Al-mahallawi, Abdulaziz Mohsen, et al.. (2022). Improvement of doxorubicin radioiodination and in-vivo cancer suppression via loading in nanosilver system. Applied Radiation and Isotopes. 187. 110288–110288. 3 indexed citations
6.
Amin, A. M., et al.. (2021). Radioiodination of Quetiapine and Cyclobenzaprine as Brain Monitoring Agents: Comparative Study on SPECT Imaging. Arab Journal of Nuclear Sciences and Applications. 0(0). 9–18.
7.
Al-mahallawi, Abdulaziz Mohsen, et al.. (2020). Enhancing Tumor Targeting Efficiency of Radiolabeled Uridine (via) Incorporation into Nanocubosomal Dispersions. Cancer Biotherapy and Radiopharmaceuticals. 35(3). 167–176. 5 indexed citations
8.
Amin, A. M., et al.. (2020). Biological Screening and Radiolabeling of Raptinal as a Potential Anticancer Novel Drug in Hepatocellular Carcinoma Model. European Journal of Pharmaceutical Sciences. 158. 105653–105653. 7 indexed citations
9.
Amin, A. M., et al.. (2020). Radiolabeling of lacosamide using highly purified rhenium-188 as a prospective brain theranostic agent. Nuclear Science and Techniques. 31(10). 1 indexed citations
10.
Amin, A. M., et al.. (2020). Preliminary evaluation of the radiotherapeutic efficacy of 131I-atorvastatin in rats with hepatocellular carcinoma. Nuclear Science and Techniques. 31(11). 5 indexed citations
11.
Amin, A. M., et al.. (2018). Formulation and Biodistribution of 99mTc-Dacarbazine, a Radioligand for Neoplasm Imaging. Radiochemistry. 60(2). 208–214. 2 indexed citations
12.
Al-mahallawi, Abdulaziz Mohsen, et al.. (2017). Comparative study on radiolabeling and biodistribution of core-shell silver/polymeric nanoparticles-based theranostics for tumor targeting. International Journal of Pharmaceutics. 529(1-2). 123–133. 35 indexed citations
13.
Amin, A. M., et al.. (2014). Iodine-125-Chlorambucil as Possible Radio Anticancer for Diagnosis and Therapy of Cancer: Preparation and Tissue Distribution. British Journal of Pharmaceutical Research. 4(15). 1873–1885. 7 indexed citations
14.
Amin, A. M., et al.. (2013). Radioiodination and biological evaluation of valsartan as a tracer for cardiovascular disorder detection. Natural Science. 5(4). 526–531. 10 indexed citations
15.
Sanad, M. H. & A. M. Amin. (2013). Optimization of labeling conditions and bioevalution of 99m Tc-Meloxicam for inflammation imaging. Radiochemistry. 55(5). 521–526. 36 indexed citations
16.
Amin, A. M., et al.. (2013). Radiochemical and biological characterization of 99m Tc-piracetam for brain imaging. Radiochemistry. 55(6). 624–628. 39 indexed citations
17.
Ibrahim, Ismail, et al.. (2010). Preparation of radioiodo-metoprolol and its biological evaluation as a possible cardiac imaging agent. Radiochemistry. 52(2). 212–216. 1 indexed citations
18.
Amin, A. M., et al.. (2009). Organic synthesis and biological evaluation of novel “3 + 1” mixed ligands of technetium-99m Gabapentin as receptor imaging agents. Journal of Radioanalytical and Nuclear Chemistry. 283(1). 55–62. 6 indexed citations
19.
Amin, A. M., et al.. (2009). Radiolabeling of thioguanine with 125I for diagnosis and therapy: in vitro and in vivo evaluation. Journal of Radioanalytical and Nuclear Chemistry. 283(2). 273–278. 11 indexed citations
20.
Amin, A. M., et al.. (2009). Radioiodination, purification and bioevaluation of Piroxicam in comparison with Meloxicam for imaging of inflammation. Journal of Radioanalytical and Nuclear Chemistry. 280(3). 589–598. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adli A. Selim Breakdown of academic impact, for papers by Emilija Janevik-Ivanovska Breakdown of academic impact, for papers by Makbule Aşıkoğlu Breakdown of academic impact, for papers by Mostafa Erfani Breakdown of academic impact, for papers by Silvana Mansueto Breakdown of academic impact, for papers by David Hoskovec Breakdown of academic impact, for papers by Wojciech Latos Breakdown of academic impact, for papers by George Makris Breakdown of academic impact, for papers by Kübra Durkan Breakdown of academic impact, for papers by Hailing Tang
Rankless by CCL
2026